|
業務類別
|
Biotechnology |
|
業務概覽
|
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913. |
| 公司地址
| 1500 Liberty Ridge Drive, Suite 321, Wayne, PA, USA, 19087 |
| 電話號碼
| +1 410 522-8707 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.avalotx.com |
| 員工數量
| 33 |
| Dr. Garry A. Neil, M.D. |
Director, President and Chief Executive Officer |
美元 590.00K |
10/04/2026 |
| Mr. Paul Varki |
Chief Legal Officer |
-- |
10/04/2026 |
| Mr. Christopher Ryan Sullivan |
Chief Financial Officer and Principal Accounting Officer |
-- |
10/04/2026 |
| Dr. Mittie Doyle, F.A.C.R.,M.D. |
Chief Medical Officer |
美元 512.50K |
10/04/2026 |
| Ms. Jennifer Riley |
Chief Strategy Officer |
-- |
10/04/2026 |
| Mr. Taylor Boyd |
Chief Business Officer |
美元 116.25K |
10/04/2026 |
|
|
| Dr. Gilla Kaplan,PhD |
Independent Director |
10/04/2026 |
| Mr. Michael T. Heffernan, R.Ph. |
Chairman of the Board |
10/04/2026 |
| Dr. Garry A. Neil, M.D. |
Director, President and Chief Executive Officer |
10/04/2026 |
| Mr. Kevin R. Lind |
Independent Director |
10/04/2026 |
| Dr. Rita I. Jain, M.D. |
Independent Director |
10/04/2026 |
| Mr. Aaron Kantoff |
Independent Director |
10/04/2026 |
| Ms. Samantha Truex |
Independent Director |
10/04/2026 |
| Mr. Ron Philip |
Director |
23/06/2026 |
|
|
|
|
